Antibodies that bind to ceacam5

CL202602017A1Pending Publication Date: 2026-07-24F HOFFMANN LA ROCHE & CO AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202602017
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-12-18
Filing Date: 2026-06-16
Publication Date: 2026-07-24

Application Information

Patent Timeline

18 Dec 2024

Priority

16 Jun 2026

Application

CL202602017

24 Jul 2026

Publication

CL202602017A1

IPC: A61P35/00; A61K39/00; C07K16/28; C07K16/30

CPC: C07K16/2803; C07K2317/92; A61K2039/505; C07K16/3007; C07K2317/24; C07K2317/567; C07K2317/31; C07K16/2809

Inventors: FERRARA KOLLER Claudia; KOENIG Maximiliane

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates generally to antibodies that bind to CEACAM5. Furthermore, the present invention relates to polynucleotides encoding such antibodies, and to vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods for using them in the treatment of a disease.

Need to check novelty before this filing date? Find Prior Art